ICR has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management.
The Institute of Clinical Research (ICR) has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management. The former event is scheduled for December 9, while the latter will take place on December10-11.
Other eye-catching training sessions being organized by ICR are on skills and competencies of a clinical trials manager (October 9-10), effective clinical trial management (November 11-13), and essentials of clinical trials monitoring (November 25).
ICR is a not-for-profit organization that provides education and training, conferences and networking events, and news updates and analysis on all aspects of clinical research. Members are engaged in all aspects of work in clinical research, both directly and in the support services. It was founded in 1978 as ACRPI (Association of Clinical Research for the Pharmaceutical Industry), and changed its name to ICR in 2000. Its head office is in Maidenhead, Berkshire, U.K., and it has over 3000 members in 49 countries around the world.
For further details, contact icrenquiries@yahoo.co.uk or visit http://www.icr-global.org/home/.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.